OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

HLA-DRB1 Alleles as Genetic Risk Factors for the Development of Anti-MDA5 Antibodies in Patients with Dermatomyositis
Zhiyong Chen, Yan Wang, Masataka Kuwana, et al.
The Journal of Rheumatology (2017) Vol. 44, Iss. 9, pp. 1389-1393
Closed Access | Times Cited: 45

Showing 1-25 of 45 citing articles:

Dermatomyositis: Clinical features and pathogenesis
Madeline E. DeWane, Reid A. Waldman, Jun Lu
Journal of the American Academy of Dermatology (2019) Vol. 82, Iss. 2, pp. 267-281
Closed Access | Times Cited: 326

239th ENMC International Workshop: Classification of dermatomyositis, Amsterdam, the Netherlands, 14–16 December 2018
Andrew L. Mammen, Yves Allenbach, Werner Stenzel, et al.
Neuromuscular Disorders (2019) Vol. 30, Iss. 1, pp. 70-92
Closed Access | Times Cited: 207

Dermatomyositis With Anti-MDA5 Antibodies: Bioclinical Features, Pathogenesis and Emerging Therapies
Anaïs Nombel, Nicole Fabien, Frédéric Coutant
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 178

Anti-MDA5 antibody-positive dermatomyositis: pathogenesis and clinical progress
Xin Lu, Qinglin Peng, Guochun Wang
Nature Reviews Rheumatology (2023) Vol. 20, Iss. 1, pp. 48-62
Closed Access | Times Cited: 49

Dermatomyositis Clinical and Pathological Phenotypes Associated with Myositis-Specific Autoantibodies
Paige W. Wolstencroft, David Fiorentino
Current Rheumatology Reports (2018) Vol. 20, Iss. 5
Closed Access | Times Cited: 96

Prevalence of interstitial lung disease in polymyositis and dermatomyositis: A meta-analysis from 2000 to 2020
Kunyan Sun, Yong Fan, Yunxia Wang, et al.
Seminars in Arthritis and Rheumatism (2020) Vol. 51, Iss. 1, pp. 175-191
Closed Access | Times Cited: 90

Understanding and managing anti-MDA 5 dermatomyositis, including potential COVID-19 mimicry
Pankti Mehta, Pedro Machado, Latika Gupta
Rheumatology International (2021) Vol. 41, Iss. 6, pp. 1021-1036
Open Access | Times Cited: 82

Single-cell profiling reveals distinct adaptive immune hallmarks in MDA5+ dermatomyositis with therapeutic implications
Yan Ye, Zechuan Chen, Shan Jiang, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 56

Bench to bedside review of myositis autoantibodies
Boaz Palterer, Gianfranco Vitiello, Alessia Carraresi, et al.
Clinical and Molecular Allergy (2018) Vol. 16, Iss. 1
Open Access | Times Cited: 72

Autoimmunity against melanoma differentiation–associated gene 5 induces interstitial lung disease mimicking dermatomyositis in mice
Yuki Ichimura, Risa Konishi, Tadatsune Iida, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 16
Closed Access | Times Cited: 5

Sequenzielle Autoimmunität? Der seltene Fall einer MDA5-Dermatomyositis und Sarkoidose
Patrick Kremer, Nikolas Ruffer, Tim Oqueka, et al.
Zeitschrift für Rheumatologie (2025)
Open Access

Dermatomyositis autoantibodies: how can we maximize utility?
Luqman Mushila Hodgkinson, Tiffany Wu, David Fiorentino
Annals of Translational Medicine (2021) Vol. 9, Iss. 5, pp. 433-433
Open Access | Times Cited: 35

Myositis-Related Interstitial Lung Diseases: Diagnostic Features, Treatment, and Complications
Courtney Shappley, Julie J. Paik, Lesley Ann Saketkoo
Current Treatment Options in Rheumatology (2019) Vol. 5, Iss. 1, pp. 56-83
Closed Access | Times Cited: 36

The seasonality of Dermatomyositis associated with anti-MDA5 antibody: An argument for a respiratory viral trigger
S. Toquet, Benjamin Granger, Y. Uzunhan, et al.
Autoimmunity Reviews (2021) Vol. 20, Iss. 4, pp. 102788-102788
Closed Access | Times Cited: 29

Novel susceptibility alleles in HLA region for myositis and myositis specific autoantibodies in Korean patients
Eun Ha Kang, Dong Jin Go, Tsuneyo Mimori, et al.
Seminars in Arthritis and Rheumatism (2019) Vol. 49, Iss. 2, pp. 283-287
Closed Access | Times Cited: 30

Roles of biomarkers in anti‐MDA5 ‐positive dermatomyositis, associated interstitial lung disease, and rapidly progressive interstitial lung disease
Xiaomeng Li, Yongmei Liu, Linlin Cheng, et al.
Journal of Clinical Laboratory Analysis (2022) Vol. 36, Iss. 11
Open Access | Times Cited: 17

WDFY4 polymorphisms in Chinese patients with anti-MDA5 dermatomyositis is associated with rapid progressive interstitial lung disease
Li Guo, Xueliang Zhang, Weilin Pu, et al.
Lara D. Veeken (2023) Vol. 62, Iss. 6, pp. 2320-2324
Closed Access | Times Cited: 9

A Review of Myositis-Associated Interstitial Lung Disease
Renuka Kannappan, R Arun Kumar, Kimberly Cichelli, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 14, pp. 4055-4055
Open Access | Times Cited: 3

The Genetics of Autoimmune Myositis
Janine A. Lamb
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 12

Genetics of idiopathic inflammatory myopathies: insights into disease pathogenesis
Simon Rothwell, Hector Chinoy, Janine A. Lamb
Current Opinion in Rheumatology (2019) Vol. 31, Iss. 6, pp. 611-616
Open Access | Times Cited: 20

Disease characteristics and clinical outcomes of adults and children with anti-MDA-5 antibody-associated myositis: a prospective observational bicentric study
Saikumar Dunga, Chengappa Kavadichanda, Latika Gupta, et al.
Rheumatology International (2021) Vol. 42, Iss. 7, pp. 1155-1165
Closed Access | Times Cited: 16

Page 1 - Next Page

Scroll to top